Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out $DATI 's accelerated company, Fundanna.com 's new client, 500 N 3rd St, LLC (Real Estate Investment For The Cannabis Industry) (http://500n.us/7) http://globenewswire.com/news-release/2018/01/04/1283347/0/en/Digital-Arts-Media-Network-Accelerated-Company-Fundanna-Inc-Adds-New-Cannabis-Startups-to-Crowd-Funding-Platform.html
BLDV UPDATE: Three Core Areas of Focus https://backend.otcmarkets.com/otcapi/company/dns/news/document/29976/content
$LFER Mr. Leonzo stated, “First and foremost to our existing shareholders, I want to thank them for their patience over the past several years. While we have had our ups and downs, recently we have had a very good tailwind and momentum carrying us into this year. In 2018, we have already accomplished all the items we have set out to and stated that we would. To our existing and potential investors, we encourage them to look at the dynamics of our enhanced business model, the announcements regarding the growth of our own brands, where we place them and how we distribute them. At the end of the day the development of our own brands will create a strong foundation for significant and sustainable future growth.”
$GRCU ~ Green Cures is made up of two divisions:
Original Hollywood Hemp™ ~ Hemp activated Health, beauty, skin care, hair care, spices, fashion, food products and beverages with the active ingredients of hemp.
Iconic Beverages™ ~ Beverage division includes hemp infused beverages which will feature iconic celebrities with exclusive licenses owned by GRCU and its shareholders.
Learn more at: http://www.grcustock.com
RNVA - CEO just purchased 26mil shares!!!! .011!!!!!
MSPC on way down, get in the next trip ZZZer break out, AHIX or TGGI
$TPAC everyone loves a good block party
$ETBI: .0051 ON IT'S WAY OVER THE MOON, HOPE YOU'RE AT LEAST WATCHING
THE KRAKEN IS ABOUT TO BE RELEASED
*CLEAN L2, NO DILUTION, BIO-TECH TURNAROUND IN PLAY
52 WEEK HIGH=.045
*DD HERE:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139132956
Take a look at $GRCU's company profile https://www.otcmarkets.com/stock/GRCU/profile
OHBK -40% 012 $340 left then 02 GRAB em!!!!!!!!!!!1
JAMN .0004, THC coffee in CO. and NATIONALLY!!!
https://www.barchart.com/stocks/quotes/JAMN
New CEO Chris Plant said months ago they are going to now focus on THC Coffee in CO and NATIONALLLY. Maybe the time has come for JAMN to really jam!
https://www.bizjournals.com/denver/news/2017/04/26/a-different-potcolorado-coffee-company-to.html
Jammin Java Corp., the Denver company that was started by the son of reggae singer and marijuana enthusiast Bob Marley, said it will introduce cannabis coffee for the Colorado market, including THC and CBD based coffees. "The fact we are located in Colorado, where cannabis is recreationally legal, will give us a competitive advantage when we start selling cannabis coffee drinks throughout the state. Priority number one is making a great tasting coffee drink, and a close number two is establishing ourselves as the premium cannabis coffee drink in Colorado. Once we accomplish that, we will look to start cannabis coffee drinks in the other legally permitted states," said Chris Plant, CEO of Jammin Java, in a statement.
CAVE CREEK, AZ -- High Performance Beverage Co. said it has entered into a joint venture with Jammin Java Corp. to develop THC- and CBD-based canned and bottled coffees for sale in Colorado. They also plan to develop mainstream RTD coffee and energy drinks for national distribution. "The fact that Jammin Java is already a well-established coffee company that is located in Colorado reaps multiple benefits and competitive advantages in the areas of THC and CDB coffee drinks," said HPBC chief executive Toby McBride. "We are extremely confident that Jammin Java will be able to have a significant impact on the Colorado market before entering additional states that are legally permitted."
JAGX wow! L2 flying faster than u can see!
JAGX .42 wheeeeee $1?????
JAGX .43 (200%+) MONSTER BLAST OFF!!! told ya (@.19c) $1 coming!!!!!!!!!!!!
JAGX .36 wheeeeee
ADAC news was super good finally getting noticed
$VRTHF Veritas Pharma Provides Corporate Update on Q1 2018
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an official corporate update on its achievements, related scientific activities and growth strategies for the first quarter of fiscal 2018.
New Laboratory Space
The Company is presently looking at prospective office and research lab space on the campus of the University of British Columbia (“UBC”) with the aim of expanding its operations in Q3 of this year.
Product Pipeline and Human Trials
In January 2018, Veritas' subsidiary, Cannevert Therapeutics Ltd. (“CTL”), signed a clinical research agreement with Puerto Rico’s Fundación de Investigación (“FDI”) to perform human trials of its lead cannabis strain, CTL-X, for targeting pain management. Since then, FDI has prepared submissions as well as made formal presentations about the proposed study design to local regulatory authorities. It is anticipated that approvals for the conduct of this study will come at the end of Q1 2018 with its immediate start in Q2 2018. The Institute for Medical Cannabis Corporation (“IMC”) of Puerto Rico is still on track to provide CTL with the necessary placebo and specific cannabis strain for the upcoming human studies at FDI.
Health Canada Dealer Licence
In December 2017, Veritas announced that Health Canada had issued its subsidiary CTL a dealer licence (no. 2018/6970) under Health Canada’s Section 9.2 of the Narcotic Control Regulations (“NCR”). This will allow CTL to possess, produce, analyze, sale, send, transport, and deliver cannabis, hemp and related products and to be a commercial service provider of chemistry and biological testing services for licensed producers under Health Canada guidelines. Since then, Cannevert has been working to obtain more diverse cannabis strains from various parts of the World to investigate their therapeutic potential. The dealer licence allows CTL to greatly accelerate its research and development and expand access to various cannabis strains with potentially therapeutic capacity.
Cannevert Therapeutics Cancer Research Project
In November 2017, the Company announced that its research arm CTL had initiated a cancer research project with Dr. Dmitri Petchkovski of Fibroblast Consulting in Vancouver, to assess the effects of several human cancer cell lines against select cannabis strains, along with standard clinical chemotherapeutic drugs for comparison. Dr. Petchkovski will specifically investigate lung, prostate, colon, breast, and melanoma cancer cell lines.
Sechelt Organic ACMPR Application
Veritas’ subsidiary, Sechelt Organic Marijuana Corp. (“SOM”), currently owns a secure commercial facility and land located in Sechelt, British Columbia, Canada. Since July 4, 2014, SOM has had an application with Health Canada to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). To date, SOM has moved into the fifth (Application Review) of the seven stages of the application process and subject to clearing this stage, its awaiting Pre-Licence Inspection and Licensing.
Completion of Cannevert Therapeutics Ltd. Acquisition
From inception of Veritas Pharma, CTL was established as the exclusive research arm of Veritas through 80% acquisition of CTL. Veritas Pharma recently signed an agreement with Davidson & Company LLP to assist in providing the Company with a ‘Fairness Opinion’ on the potential value of taking over the remaining 20% of CTL. Davidson will provide their opinion on whether that value is fair based on the skillsets of the Cannevert team, their scientific and clinical accomplishments, including the acquisition of a Health Canada Dealer Licence, and the current state of the medical cannabis industry. Davidson’s final report is scheduled to be delivered to Veritas by February 28, 2018.
The Company also announces the issuance of 2,000,000 stock options at $0.65 to directors, management, and consultants of the Company for a term of twelve (12) months and the cancelation of 1,000,000 previously announced stock options.
About Veritas Pharma Inc.
Veritas Pharma Inc. is an emerging pharmaceutical and IP development company, who, through its 80% owned subsidiary Cannevert Therapeutics Ltd. ("CTL"), is advancing the science behind medical cannabis. It is the Company’s aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical cannabis claims. CTL’s unique value proposition uses a low-cost research and development model to help drive shareholder value, and speed-to-market. Veritas investment in CTL is led by strong management team, bringing together veteran academic pharmacologists, anesthetists & chemists. The company's commercial mission is to patent protect IP (cultivars & strains) and sell or license to cancer clinics, insurance industry and pharma, targeting multi-billion dollar global markets.
Veritas Pharma Inc. is a publicly traded company which trades in three countries including Canada, on the Canadian Stock Exchange under the ticker VRT; in the United States, on the OTC under the ticker VRTHF; and in Germany, on the Frankfurt exchange under the ticker 2VP.
For more information, please visit our website: veritaspharmainc.com
On behalf of the Board of Directors
"Dr. Lui Franciosi"
Dr. Lui Franciosi
President and Chief Executive Officer
Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com and on the CSE website at www.thecse.com.
Investor and Public Relations Contact
Veritas Pharma Inc.
Sam Eskandari
Telephone: +1.416.918.6785
Email: ir@veritaspharmainc.com
Website: www.veritaspharmainc.com
The CSE has not reviewed, nor approved or disapproved the content of this press release.
Source: Veritas Pharma Inc.
https://www.otcmarkets.com/stock/VRTHF/news/story?e&id=1009635
STSC...About to announce Reverse-Merger...Stocks on fire...Check it out..
You dont want to miss out on a RM well before most find out.
This is a very seasoned CEO who is not a stinky pinky scammer. Filing coming in tot he shell, and CEO states announcements coming.
JAGX trading fast and furious here 115%
JAGX .30 (115%+) HOLY COW!! - MULTI MEGA RUNNER!!!!
$CELZ DD
Wow what a crazy ride with this one. It would seem dilution is finally finished with this which means we can now start thinking about going back up! This stock has a lot of news in the pipeline and it can move quick with only 200,000,000 million O/S. With it sitting at a new 52- week low and a high of .70 I can see this going to new highs as this company announces news. This company has already said they want to stay QB tier in 2018 so they need to get back to .01 minimum. On top of that the main treatment they have been researching and studying is now ready for commercialization. This is a potential 10 billion dollar industry now going out to the market this year. They also have other things in the pipeline. So super exciting times with this one and it is the perfect time to get in IMO.
VMSI and RSHN get in going up$$$$$$$$
JAGX .27 (up 95%) $2+++ COMING!!! MONSTER RUN FDA APPROVAL
HPIL refuting imagine that HPIL Holding (HPIL) Refutes Content of Press Release on Accesswire GlobeNewswire "Press Releases"
SANFORD, Mich. , March 08, 2018 (GLOBE NEWSWIRE) -- HPIL HOLDING (the Company) (OTC Pink:HPIL) announced that a false press release has been posted on Accesswire.com concerning HPIL .
The false press release, HPIL HOLDING Announces Corporate Buyout; Initiates Agreement, stated that HPIL had received an offer from Telesun Technology to buy out HPIL at $0.01 a share, and purported to quote HPIL's CEO, Nitin Amersey .
In actual fact, HPIL has no knowledge of any such offer and the CEO has not made this statement. The Company has asked Accesswire to remove this item.
Safe Harbor / Forward-Looking Statements:
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as anticipate, believe, forecast, estimate, expect, plan, potential, seek, and intend, among others. These forward-looking statements are based on the Companys current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our possible need for financing; uncertainties of technological changes; and dependence upon third parties. The Company does not undertake an obligation to update or revise any forward-looking statement. All of the Companys forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
HPIL Holding
Mr. Peter Nicosia Tel: +1 (248) 750-1015
Email: info@hpilholding.com Source: HPIL Holding
Source: HPIL HOLDING
JAGX .26 BOOOM see you $1?
LTNC .0001 getting very active lately: https://twitter.com/laborsmart
ALERT-------ALERT --- $KNDI ----- $KNDI 100% to 1000% Gains possibly
XREE here comes the turn .0025 falling crazy oversold never been down here
$GRCU 33 states and Puerto Rico have introduced pro-hemp legislation, and 24 states have defined industrial hemp as distinct from other strains of cannabis and removed barriers to its Industrial hemp is legal to grow in more than 30 countries. The United States is one of the few industrialized nations that does not currently allow the cultivation of hemp. Millions of dollars’ worth of hemp is imported into the United States each year in order to fulfill the growing demand for hemp products http://www.grcustock.com/index.php/market/
ADTM Going to ROCKET soon. Valued in pennies.
TGGI .0002s a few cheappies yet, 10-20 bagger 4 sure, https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139130736
JAGX headed to $1? big room to run!
***VOIS*** & ***NUUU*** Get in before the runs start.
ASKH wow breaking 05 thats one hellova nice chart cup developing
bgti
8
Table of Contents
General Business Risks
We are subject to the risks of current and future legal proceedings, which could have a material adverse effect on our business, financial condition, results of operations and future prospects.
At any given time, we are a defendant in various material legal proceedings and litigation matters arising in the ordinary course of business, including litigation, claims and assessments that have been asserted against acquired businesses, which we have assumed. Although we maintain insurance policies, these policies may not be adequate to protect us from all material judgments and expenses related to potential future claims and these levels of insurance may not be available in the future at economical prices or at all. A significant judgment against us, arising out of any of our current or future legal proceedings and litigation, could have a material adverse effect on our business, financial condition, results of operations and future prospects.
On July 14, 2017 a truck owned by Twiss Transport, Inc. (“ Twiss”) and driven by a Twiss employee was involved in a fatal accident in Marion County, Florida. Twiss, BT Twiss and the Company have been sued in both federal court in Pennsylvania and state court in Florida by the injured parties and the estate of the deceased. No damages have yet been specified and the defendants are vigorously defending the claims. All three defendants have notified the applicable insurance carrier .
We are indirectly involved, through Ordnance, in legal proceedings involving the termination of a DoD contract which took place in July 2011. (See Part 3, Legal Proceedings).
Our level of debt and our ability to make payments on or service our indebtedness may adversely affect our financial and operating activities or ability to incur additional debt.
Commencing with our January 1, 2009 acquisition of 3Si Holdings, Inc., we assumed certain amounts of indebtedness associated with the business operations acquired. Subsequently, we incurred additional debt with high interest rates that have hindered the Company financially.
In October 2012, we sold substantially all of the assets of Bulova Technologies Ordnance Systems LLC, andsettled significant indebtedness.
In July of 2013, we entered into the machine tool business, importing industrial machine tools and related equipment from international sources. In establishing this new line of business, we incurredcertain debt to facilitate the cultivation and marketing of a distributor / dealer network.
In January 2016 and again in July 2017, through significant acquisitions, we expanded into the freight transportation, logistics and storage businesses, making substantial investments and incurring significant amounts of debt for both equipment acquisitions and working capital.
At September 30, 2017, we have outstanding debt of approximately 38.6 million to support our operations and cash flow needs.
In the future, we may need to increase our borrowings, subject to limitations imposed on us by our debt agreements. Further discussion concerning the sale of these assets and any remaining scheduled maturities of our outstanding debt, is included in Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources
.
Our ability to make scheduled payments of principal and interest on our indebtedness and to refinance our existing debt, including the scheduled maturities of our outstanding debt, depends on our future financial performance as well as our ability to access the capital markets, and the relative attractiveness of available financing terms. We do not have complete control over our future financial performance because it is subject to economic, political, financial (including credit market conditions), competitive, regulatory and other factors affecting the defense industry, as well as commercial industries in which we operate. It is possible that in the future our business may not generate sufficient cash flow from operations to allow us to service our debt and make necessary capital expenditures. If this situation occurs, we may have to reduce costs and expenses, sell assets, restructure debt or obtain additional equity capital. We may not be able to do so in a timely manner or upon acceptable terms in accordance with the restrictions contained in our debt agreements.
Our level of indebtedness has important consequences to us. These consequences may include:
•
requiring a substantial portion of our net cash flow from operations to be used to pay interest and principal on our debt and therefore be unavailable for other purposes, including acquisitions, capital expenditures, paying dividends to our shareholders, repurchasing shares of our common stock, research and development and other investments;
•
limiting our ability to obtain additional financing for acquisitions, working capital, investments or other expenditures, which, in each case, may limit our ability to carry out our acquisition strategy;
•
increasing interest expenses due to higher interest rates on our borrowings that have variable interest rates;
•
heightening our vulnerability to downturns in our business or in the general economy and restricting us from making acquisitions, introducing new technologies and products or exploiting business opportunities; and
•
impacting debt covenants that limit our ability to borrow additional funds, dispose of assets, or repurchase shares of our common stock. Failure to comply with such covenants could result in an event of default which, if not cured or waived, could result in the acceleration of our outstanding indebtedness.
VIZC .001 falling now - .002 coming!!!
bgti
8
Table of Contents
General Business Risks
We are subject to the risks of current and future legal proceedings, which could have a material adverse effect on our business, financial condition, results of operations and future prospects.
At any given time, we are a defendant in various material legal proceedings and litigation matters arising in the ordinary course of business, including litigation, claims and assessments that have been asserted against acquired businesses, which we have assumed. Although we maintain insurance policies, these policies may not be adequate to protect us from all material judgments and expenses related to potential future claims and these levels of insurance may not be available in the future at economical prices or at all. A significant judgment against us, arising out of any of our current or future legal proceedings and litigation, could have a material adverse effect on our business, financial condition, results of operations and future prospects.
On July 14, 2017 a truck owned by Twiss Transport, Inc. (“ Twiss”) and driven by a Twiss employee was involved in a fatal accident in Marion County, Florida. Twiss, BT Twiss and the Company have been sued in both federal court in Pennsylvania and state court in Florida by the injured parties and the estate of the deceased. No damages have yet been specified and the defendants are vigorously defending the claims. All three defendants have notified the applicable insurance carrier .
We are indirectly involved, through Ordnance, in legal proceedings involving the termination of a DoD contract which took place in July 2011. (See Part 3, Legal Proceedings).
Our level of debt and our ability to make payments on or service our indebtedness may adversely affect our financial and operating activities or ability to incur additional debt.
Commencing with our January 1, 2009 acquisition of 3Si Holdings, Inc., we assumed certain amounts of indebtedness associated with the business operations acquired. Subsequently, we incurred additional debt with high interest rates that have hindered the Company financially.
In October 2012, we sold substantially all of the assets of Bulova Technologies Ordnance Systems LLC, andsettled significant indebtedness.
In July of 2013, we entered into the machine tool business, importing industrial machine tools and related equipment from international sources. In establishing this new line of business, we incurredcertain debt to facilitate the cultivation and marketing of a distributor / dealer network.
In January 2016 and again in July 2017, through significant acquisitions, we expanded into the freight transportation, logistics and storage businesses, making substantial investments and incurring significant amounts of debt for both equipment acquisitions and working capital.
At September 30, 2017, we have outstanding debt of approximately 38.6 million to support our operations and cash flow needs.
In the future, we may need to increase our borrowings, subject to limitations imposed on us by our debt agreements. Further discussion concerning the sale of these assets and any remaining scheduled maturities of our outstanding debt, is included in Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources
.
Our ability to make scheduled payments of principal and interest on our indebtedness and to refinance our existing debt, including the scheduled maturities of our outstanding debt, depends on our future financial performance as well as our ability to access the capital markets, and the relative attractiveness of available financing terms. We do not have complete control over our future financial performance because it is subject to economic, political, financial (including credit market conditions), competitive, regulatory and other factors affecting the defense industry, as well as commercial industries in which we operate. It is possible that in the future our business may not generate sufficient cash flow from operations to allow us to service our debt and make necessary capital expenditures. If this situation occurs, we may have to reduce costs and expenses, sell assets, restructure debt or obtain additional equity capital. We may not be able to do so in a timely manner or upon acceptable terms in accordance with the restrictions contained in our debt agreements.
Our level of indebtedness has important consequences to us. These consequences may include:
•
requiring a substantial portion of our net cash flow from operations to be used to pay interest and principal on our debt and therefore be unavailable for other purposes, including acquisitions, capital expenditures, paying dividends to our shareholders, repurchasing shares of our common stock, research and development and other investments;
•
limiting our ability to obtain additional financing for acquisitions, working capital, investments or other expenditures, which, in each case, may limit our ability to carry out our acquisition strategy;
•
increasing interest expenses due to higher interest rates on our borrowings that have variable interest rates;
•
heightening our vulnerability to downturns in our business or in the general economy and restricting us from making acquisitions, introducing new technologies and products or exploiting business opportunities; and
•
impacting debt covenants that limit our ability to borrow additional funds, dispose of assets, or repurchase shares of our common stock. Failure to comply with such covenants could result in an event of default which, if not cured or waived, could result in the acceleration of our outstanding indebtedness.
VIZC looking good now
VIZC .001 HUGE REBOUND COMING!! ACCULUMATIONS SEEMS ALL DONE AT THIS LEVEL.
Followers
|
8275
|
Posters
|
|
Posts (Today)
|
8
|
Posts (Total)
|
2342986
|
Created
|
12/20/05
|
Type
|
Free
|
Moderator MOMO | |||
Assistants i_like_bb_stock Cube balamidas |
*** PURPOSE of the BOARD is to alert both penny and big board stocks which are breaking out in play.
Furthermore, this board provides an open forum for both experienced and new traders alike to shares their stock picks, opinions and experiences.
At one time or another, we were all new to trading and looking for a place to learn and understand the market, which is one of the main reasons this board was created.
This forum provides new investors a place to learn and feel comfortable doing it.
*** ALERTS are based on stocks that show an acceleration of price or volume; showing signs of reversing based on their chart and volume are not suitable for all investors.
Due to the increased volatility and high risk exposure when trading penny stocks, it is possible to lose your entire investment.
Taking profits, due diligence and preservation of your initial investment is key and must be taken into consideration.
All stocks mentioned are welcome herr and range from pennies to the big boards and everything in between.
Do your own due diligence before investing and never trade more than you can afford to lose.
Traders should plan their exits before they trade and take profits the way up.
We are here to help -- let us know if we can be of any assistance.
*** A MUST HAVE for TRADERS http://www.equityfeed.com/
IMPORTANT / USEFUL LINKS
SHO LIST: http://www.nasdaqtrader.com/aspx/regsho.aspx
BUYINS.NET: http://www.buyins.net/
POST S-8 PLAYS: http://www.investorshub.com/boards/board.asp?board_id=1605
TOXIC FILINGS: http://www.investorshub.com/boards/board.asp?board_id=4318
REVERSE SPLITS: http://www.investorshub.com/boards/board.asp?board_id=3017
DEATH DROP: http://www.investorshub.com/boards/board.asp?board_id=3341
PRESS RELEASES:http://home.businesswire.com/portal/site/home/index.jsp?front_door=true
1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Complete List of Transfer Agents in the United States:
http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Stock Market Holiday Schedule
http://www.allstocks.com/html/stock_markets_holidays.html
RULES OF THE BOARD~
*** NO PERSONAL ATTACKS or VULGARITY WILL BE TOLERATED!!!
DISCLAIMER:
Opinions expressed on this board are just opinions. We are not licensed brokers.
Trading strategies discussed on this board are often high risk and are not suitable everyone.
If you consistantly lose money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU.
Following stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY.
Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do due diligence before buying or selling ANY SECURITY in the open market; are no guarantees.
TRADE WELL & REMEMBER TO TAKE PROFITS on THE WAY UP!
GOOD LUCK!
*** FOLLOW OUR ALERTS ON TWITTER ***
http://twitter.com/#!/pennystockmomo
*** FOR EARLY ALERTS SIGN UP FOR THE BREAKOUT TRADERS E-MAIL LIST ***
http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=4929
Posts Today
|
8
|
Posts (Total)
|
2342986
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |